These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1827969)

  • 1. Effects of thromboxane synthetase inhibition on immune complex glomerulonephritis.
    Longhofer SL; Frisbie DD; Johnson HC; Culham CA; Cooley AJ; Schultz KT; Grauer GF
    Am J Vet Res; 1991 Mar; 52(3):480-7. PubMed ID: 1827969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a thromboxane synthetase inhibitor on established immune complex glomerulonephritis in dogs.
    Grauer GF; Frisbie DD; Longhofer SL; Cooley AJ
    Am J Vet Res; 1992 May; 53(5):808-13. PubMed ID: 1388004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dietary n-3 fatty acid supplementation versus thromboxane synthetase inhibition on gentamicin-induced nephrotoxicosis in healthy male dogs.
    Grauer GF; Greco DS; Behrend EN; Fettman MJ; Mani I; Getzy DM; Reinhart GA
    Am J Vet Res; 1996 Jun; 57(6):948-56. PubMed ID: 8725828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a thromboxane synthetase inhibitor on eicosanoid synthesis and glomerular injury during acute unilateral glomerulonephritis in the rat.
    Cook HT; Cattell V; Smith J; Salmon JA; Moncada S
    Clin Nephrol; 1986 Oct; 26(4):195-202. PubMed ID: 3490944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of selective inhibition of thromboxane synthesis on renal function in diabetic nephropathy.
    Kontessis PS; Jones SL; Barrow SE; Stratton PD; Alessandrini P; De Cosmo S; Ritter JM; Viberti GC
    J Lab Clin Med; 1993 Mar; 121(3):415-23. PubMed ID: 8445289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the thromboxane synthesis inhibitor CGS-12970 on experimental acute renal allograft rejection.
    Mangino MJ; Brunt EM; Von Doersten P; Anderson CB
    J Pharmacol Exp Ther; 1989 Jan; 248(1):23-8. PubMed ID: 2643702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of a specific thromboxane synthetase inhibitor on development of experimental Dirofilaria immitis immune complex glomerulonephritis in the dog.
    Grauer GF; Culham CA; Dubielzig RR; Presto SK; Oberley TD; Thomas CB; Grieve RB
    J Vet Intern Med; 1988; 2(4):192-200. PubMed ID: 2976425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of a specific thromboxane synthetase inhibitor on thromboxane generation and excretion in healthy dogs.
    Longhofer SL; Johnson HC; Culham CA; Schultz KT; Grauer GF
    Am J Vet Res; 1990 Nov; 51(11):1746-50. PubMed ID: 2240799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic trial of thromboxane synthesis inhibition in the hepatorenal syndrome.
    Zipser RD; Kronborg I; Rector W; Reynolds T; Daskalopoulos G
    Gastroenterology; 1984 Dec; 87(6):1228-32. PubMed ID: 6593268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical effects of selective thromboxane A2 synthetase inhibitor in patients with nephrotic syndrome.
    Niwa T; Maeda K; Shibata M; Yamada K
    Clin Nephrol; 1988 Nov; 30(5):276-81. PubMed ID: 3214971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
    Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):658-64. PubMed ID: 3164534
    [No Abstract]   [Full Text] [Related]  

  • 14. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
    Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
    J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor.
    Smeesters C; Chaland P; Giroux L; Moutquin JM; Etienne P; Douglas F; Corman J; St-Louis G; Daloze P
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):663-9. PubMed ID: 3163209
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemodynamic roles of thromboxane A2 and prostaglandin E2 in glomerulonephritis.
    Stork JE; Dunn MJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):672-8. PubMed ID: 3859644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary excretion of prostaglandins and renal function after hepatic resection.
    Matsumata T; Yamamoto K; Shirabe K; Shimada M; Sugimachi K; Takesue F; Muto Y; Ikeda T
    Hepatogastroenterology; 1997; 44(15):774-8. PubMed ID: 9222688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a selective thromboxane A2 synthetase inhibitor on immune complex glomerulonephritis.
    Saito H; Ideura T; Takeuchi J
    Nephron; 1984; 36(1):38-45. PubMed ID: 6228742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of short-term cyclosporine administration in rats on renin-angiotensin and thromboxane A2: possible relevance to the reduction in glomerular filtration rate.
    Perico N; Zoja C; Benigni A; Ghilardi F; Gualandris L; Remuzzi G
    J Pharmacol Exp Ther; 1986 Oct; 239(1):229-35. PubMed ID: 3531461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.